Document:

EX-10.1

 Exhibit 10.1 
 MedAssets 
 Separation and Release Agreement 

PLEASE READ THIS AGREEMENT CAREFULLY; IT INCLUDES A RELEASE OF 

ALL KNOWN AND UNKNOWN CLAIMS 
 The purpose of this document is to set forth the terms and conditions of the Separation Agreement (the “Agreement”) between you and MedAssets, Inc. and MedAssets Services, LLC (collectively, the
“Company”) with respect to the termination of your employment. 
  

	 	1.	You agree and understand that your employment will end as of the close of business on September 30, 2011 (“Last Day of Employment”). Your last day of
active employment will be September 7, 2011 (“Final Workday”). Effective as of your Final Workday, you will transition all of your workload to other Company employees, as appropriate. Between the Final Workday and the Last Day of
Employment, you will remain an employee of the Company to assist with any remaining workload transition questions or issues. Between the Final Workday and the Last Day of Employment, you will be free to explore alternative employment opportunities,
accept alternative employment, and commence employment with another company. 

  

	 	2.	In consideration of and subject to (x) the undertakings and promises made by you as set forth in this Agreement, and (y) your execution, delivery and
non-revocation of the general release of claims attached hereto as Exhibit A within 14 days following the Last Day of Employment, the Company will provide you with the following: 

 

	 	a.	 $570,000 in separation pay (which represents 18 months’ of your base annual salary plus an additional $45,000). You agree that these payments are
amounts you are not otherwise entitled to receive. These amounts will be net of all statutory and authorized withholdings and deductions, and will be made in accordance with the Company’s payroll practices as in effect at the time of payment.
Of the total amount described above, $525,000 will be paid in substantially equal installments over the 18 month period beginning on the Last Day of Employment; provided that the first payment shall not be made until the first regularly scheduled
pay period following the 60th day from the Last Day of
Employment; provided, further, that the first payment will include a catch-up payment for any installments that accrued during the 60-day waiting period plus the additional $45,000 described above; and 

 

	 	b.	an extension to March 29, 2013, ending at 5:00 p.m. Eastern Time, on that date, of the time period during which you may exercise any equity rights that have fully
vested to you as of the last day of employment. The extension set forth in this Paragraph 2(b) supersedes and replaces any other time period in which you previously were authorized to exercise any of your vested equity rights under the
Employment Agreement between you and MedAssets, Inc., dated August 22, 2007, as amended as of May 2, 2011 (the “Employment Agreement”), and under any and all other agreements between you and the Company, including, without
limitation, any and all stock option agreements and agreements governing the exercise of any restricted stock units or stock appreciation rights (collectively, “Equity”). 

 

	 	3.	 You acknowledge and agree that the payments and extended exercise period described in Paragraph 2, above, are negotiated payments and rights. These
negotiated payments and rights are intended by both you and the Company to satisfy in full any and all obligations on the part of the Company to make any payments or to allow any vesting, accelerated or

	 	
not, of equity under the Employment Agreement, or any agreement granting you any Equity or any right to receive any Equity. 

 

	 	4.	In addition to the payments and extended exercise period described in Paragraph 2, above, the Company acknowledges its obligation to compensate you for time you worked
through your Last Day of Employment, at your current annual salary, less statutory and authorized withholdings and deductions. 

  

	 	5.	COBRA. As of your Last Day of Employment, you have the option of exercising any rights to continue your participation in the Company’s group health
insurance plans available to you under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”). You will receive an enrollment form and necessary information under separate cover on or before October 14, 2011. Any
entitlement to continue your participation in such plans shall be only as permitted under COBRA and at your own expense. 

  

	 	6.	Non-Interference. You remain bound to the Employment Agreement that you signed, a copy of which is attached to this Agreement as Exhibit B. Both you and
the Company recognize the importance of compliance with the “Non-Interference” requirements of that agreement. If you execute this Agreement, then you are also bound to the duties and responsibilities set forth in this Agreement.

  

	 	7.	Good Faith Requirement. Notwithstanding any other provision of this Agreement or the Employment Agreement, any failure by you to comply with any of the
provisions in this Agreement or in the Employment Agreement will result in immediate forfeiture of any and all rights to the payments and extended exercise period described in Paragraph 2 above. In addition, the Company may seek repayment of any of
the payments described in Paragraph 2 already paid to you. 

  

	 	a.	Company Property. Except as set forth in Paragraph 7(a)(i) through 7(a)(iii), below, you must return all Company property and equipment on or before your last
day of work (as defined in Paragraph 1 above), including all documents, cell-phones, laptops, Company credit cards, air cards, thumb drives, identification badges, keys, and any other equipment, electronic data, hard-copy information, and supplies
in your possession. If you have copied or stored any electronic data that constitutes Confidential Information (as defined in the Employment Agreement) onto any electronic data storage device which is not the property of the Company, then you must
tender the device to the Company so that the Company can remove the applicable electronic data. You may retain permanently, at no cost to you, the following: 

 

	 	i.	One of the two computers that the Company had issued to you: identification number MAC12L2532B (Dell XT2 Laptop), so long as on or before your Last Day of Employment,
you bring that laptop computer to the Company to enable the Company’s information technology personnel to remove all Company data from the laptop computer’s hard drive; 

 

	 	ii.	The Company-purchased printer that you have maintained at your home (Brother 9970MFC); 

  
 2 

	 	iii.	Your Company-issued cell phone (Apple iPhone 4), so long as: on or before your Last Day of Employment you bring that cell phone to the Company to enable the
Company’s information technology personnel to remove all Company data from the cell phone’s storage card or drive; you port the telephone number to a personal cell phone bill effective as of October 1, 2011; and, if you receive any
communications to the phone relating to Company business, you provide the caller with instructions for contacting the appropriate Company executive. The Company will have no obligation related to maintaining cellular service for you or on your
behalf. 

  

	 	b.	Airline Credits. The Company has no ownership rights or interest in any airline mileage credits or other airline credits, and it will not dispute your ownership
rights or interest in any and all unused airline credits that you have accumulated during your employment with the Company. 

  

	 	c.	Reaffirmation of Confidentiality Obligations. You reaffirm your obligation to never disclose to any third party any Confidential Information (as that term is
defined and as that restriction is further described in the Employment Agreement). You understand and reaffirm that these duties of confidentiality survive the last day of employment. 

 

	 	d.	Confidentiality of this Agreement’s Terms. You must not disclose or disseminate this Agreement, or any of its terms, to anyone, except as set forth in this
Paragraph 7(d). This means that you cannot disclose this Agreement in any form to any current or former employees of the Company, or to the general public or to the media. You may discuss this Agreement with your spouse, with your legal
representative, and with your personal accountant, so long as you inform them that this Agreement is confidential, and must not be further disclosed. You may also disclose this Agreement if required by law, or as necessary to comply with law, or as
necessary to fulfill the terms of this Agreement. 

  

	 	8.	Legal Participation and Status. 

  

	 	a.	Testimony. Because full compliance with all laws and regulations is important to the Company, you agree that you shall cooperate with all members of the Company
Group (as defined in the Employment Agreement) with respect to any pending or future litigation or other claim or investigation involving any member of the Company Group regarding which you have relevant information. Cooperation, as used herein,
means: (1) you shall meet with Company Group representatives and attorneys at reasonable times and places to discuss facts and other matters related to litigation or other claims (this includes travel to such locations as requested by a member
of the Company Group at its expense); (2) you shall appear and provide testimony if requested by a member of the Company Group (this includes travel to such locations as requested by a member of the Company Group at its expense); and
(3) if you ever testify in any litigation or other claim against any member of the Company Group, you shall provide full, complete, and truthful testimony, with no expectation of compensation. To the extent that a member of the Company Group
requests you travel more than 50 miles away from your home either to meet with Company Group representatives and/or attorneys, and/or testify in a legal proceeding of any kind, then the Company will reimburse you for your actual travel expenses,
consistent with the Company’s then-current travel policies and procedures. 

  
 3 

	 	b.	Restricted Person Status. The Company acknowledges and agrees that you are released of your status as a “restricted person” as defined in the
Company’s Insider Trading Policy as of the last day of employment. 

  

	 	9.	Non-Disparagement. 

  

	 	a.	Your Non-Disparagement Obligations. You agree that you will not now, or in the future, make any statements, written or oral, unless such statements are truthful
disclosures required by applicable law, or take such action as (a) will discredit the Company, any of its products, or the reputation of any of its directors, officers or employees, or (b) damage the ability of the Company, or any of its
directors, officers, or employees to do business in the communities in which they conduct their affairs. 

  

	 	b.	The Company’s Non-Disparagement Obligations. The Company will not now, or in the future, make any statements, written or oral, unless such statements
are truthful disclosures required by applicable law, or take such action as (a) will discredit you, your job performance with the Company, or your skill sets and capabilities, or (b) damage your ability to obtain employment or to do
business in the communities in which you conduct your affairs.

  

	 	c.	Statements Regarding Departure. You and the Company agree that contemporaneously with, and following, your execution of this Agreement and your separation
from employment with the Company, the Company will be entitled to make certain statements regarding your separation from employment. At the present time, you and the Company envision conveying information regarding your separation to the
following different constituencies: i) the Securities & Exchange Commission; ii) the Company’s Board of Directors and Executive management team; iii) the employees you supervised in the Revenue Cycle Technology division, as well as
other employees of the Company; and iv) prospective employers with whom you are seeking employment. As to each of these different constituencies, the information the Company will provide regarding your separation from employment shall be as
follows: 

  

	 	i.	i. SEC disclosures: The 8-K disclosure will be made in the ordinary course of business. The Company agrees that the language used in the 8-K will be substantially
similar to the language set forth in Exhibit C to this Agreement. Board and Executives: The Company will consider any proposed communication plan, strategy, and/or talking points provided by you, but the Company reserves the right to finalize
and deliver any communications to the Board and to the Company’s executive leadership, if needed and as needed, in its sole discretion. 

  

	 	ii.	RCT Employees and Other Company Employees: The Company will consider any proposed communication plan, strategy, and/or talking points provided by you, but the
Company reserves the right to finalize and deliver any communications to the Company’s employees, if needed and as needed, in its sole discretion; and 

 

	 	iii.	 Prospective Employers: Although the Company’s ordinary employment policies, practices, and procedures will provide a neutral employment
reference, which includes verification of your dates of employment and job 

  
 4 

	 	
title, the Company represents it will provide a positive reference. No other information will be disclosed unless authorized by you, in writing. The Company will not provide any other information
to prospective employers. 

  

	 	10.	Your Release of the Company. In consideration of the payments provided to you in connection with the termination of your employment with the Company, you agree
to release any and all claims arising out of your employment and termination of employment, in accordance with subparagraphs a, b, and c of this Paragraph 10. 

 

	 	a.	Except for the Company’s obligation under this Agreement, YOU AGREE FOR YOURSELF AND
YOUR HEIRS, EXECUTORS, ADMINISTRATORS, SUCCESSORS, AND ASSIGNS TO FOREVER RELEASE
AND DISCHARGE THE COMPANY AND ITS SUBSIDIARIES, RELATED COMPANIES, PARENTS,
SUCCESSORS AND ASSIGNS, OFFICERS, DIRECTORS, AGENTS, EMPLOYEES AND FORMER EMPLOYEES
FROM ANY AND ALL CLAIMS, DEBTS, PROMISES, AGREEMENTS, DEMANDS, CAUSES OF
ACTION, ATTORNEYS’ FEES, LOSSES AND EXPENSES OF EVERY NATURE WHATSOEVER, KNOWN
OR UNKNOWN, SUSPECTED OR UNSUSPECTED, FILED OR UNFILLED, ARISING PRIOR TO
THE EFFECTIVE DATE OF THIS AGREEMENT, OR RISING OUT OF OR IN
CONNECTION WITH YOUR EMPLOYMENT BY AND TERMINATION FROM THE COMPANY OR
ANY AFFILIATE OF THE COMPANY. This total release includes, but is not limited to, all claims arising directly or indirectly from your employment with the Company and the
termination of that employment; claims or demands related to salary, bonuses, commissions, stock, stock options, vacation pay, fringe benefits and expense reimbursements pursuant to any federal, state, or local law or cause of action, including, but
not limited to, breach of contract, breach of the implied covenant of good faith and fair dealing, infliction of emotional harm, wrongful discharge, violation of public policy, defamation and impairment of economic opportunity; and any claims for
violation of the Age Discrimination in Employment Act of 1967 (“ADEA”), Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the Civil Rights Act of 1866, 42 U.S.C. § 1981, the Americans with
Disabilities Act of 1990, the Rehabilitation Act, the Family and Medical Leave Act of 1993, the Equal Pay Act, Executive Order 11246, the Fair Labor Standards Act, the Genetic Information Non-Disclosure Act, USERRA, WARN Act, and any and all claims
arising under Georgia law dealing with employment or contract (including claims for or regarding wages, hours, discrimination, civil rights, torts— such as, but not limited to, negligence— and any other federal, state or local employment
or anti-discrimination laws). 

  

	 	b.	You further agree that you will not file suit against any of the aforementioned parties or individuals with regard to any claims or liabilities released herein. You
further agree not to accept, recover, or receive any monetary damages or any other form of relief which may arise out of or in connection with any administrative remedies, which may be filed with or pursued independently by any governmental agency
or agencies, whether federal, state, or local. 

  

	 	c.	 Thus, for the purpose of implementing a full and complete release and discharge of the Company (and others released in this Paragraph 10), you
expressly acknowledge that this Agreement is intended to include in its effect, without limitation, claims and causes of action which you do not know of, or do not suspect to exist, in your favor at the time of execution hereof, and that this
Agreement contemplates extinguishment of 

  
 5 

	 	
all such claims and causes of action. By executing this Agreement, you specifically release all claims relating to your employment and its termination under ADEA, a United States federal statute
that, among other things, prohibits discrimination on the basis of age in employment and employee benefit plans. 

  

	 	d.	As a narrow and limited exception to the waiver and release in Paragraph 10.a. above, you retain all rights to receive indemnification from the Company for
third-party claims, including any applicable insurance policies such as the Company’s Directors & Officers insurance policies and/or any general corporate indemnification obligations set forth in Delaware and/or Georgia statutes, as
applicable. Additionally, nothing herein shall be construed as a waiver of any claims that cannot be waived by law including, without limitation any claims filed with the Equal Employment Opportunity Commission, the U.S. Department of Labor, or
claims under the ADEA that arise after the date of this Agreement. 

  

	 	11.	The Company’s Release of You. In consideration of the promises you made, as set forth in this Agreement, and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged by the Company, the Company agrees to release any and all claims arising out of your employment, in accordance with subparagraphs a, b, and c of this Paragraph 11; provided,
however, that nothing herein shall be construed as a release by the Company of any claim for any one or more of fraud, willful misconduct, gross negligence embezzlement or misappropriation. The Company represents that as of September 3,
2011, after a careful review of your job performance, it is not aware of any conduct or actions by you preceding the Company’s execution of this Agreement that would constitute any one or more of fraud, willful misconduct, gross negligence,
embezzlement, or misappropriation. 

  

	 	a.	Except for your obligations under this Agreement or as explicitly excluded pursuant to the previous paragraph, the Company agrees for itself and its subsidiaries,
related companies, parents, successors and assigns, officers, directors to forever release and discharge you (and your heirs, executors, administrators, successors and assigns) from any and all claims, debts, promises, agreements, demands, causes of
action, attorneys’ fees, losses and expenses of every nature whatsoever, known or unknown, suspected or unsuspected, filed or unfilled, arising prior to the effective date of this Agreement, or rising out of or in connection with your
employment by or with the Company or any affiliate of the Company. This total release includes, but is not limited to, all claims arising directly or indirectly from your employment with the Company or its affiliates; claims or demands related to
any and all aspects of your job performance for the Company or its affiliates; any and all claims based on the U.S. or any state Constitution; any and all claims based on any federal or state statute, as well as any administrative or other
regulation promulgated pursuant to a grant of statutory or rule-making authority; any and all claims based on contract or quasi-contract legal theories; any and all claims based on any tort theories, recognized in Georgia or any other state
jurisdiction; any and all claims based on your actions or failures to act in your employment with the Company or its affiliates at any time prior to the date you execute this Agreement; and any and all claims based on any statements you have made,
whether written or oral, explicit or implicit, at any time prior to the date you execute this Agreement. 

  
 6 

	 	b.	The Company further agrees that neither it nor any of its subsidiaries, related companies, parents, successors and assigns, officers, or directors will file suit
against you (or your heirs, executors, administrators, successors or assigns) with regard to any claims or liabilities released in this Paragraph 11. The Company further agrees that neither it nor any of its subsidiaries, related companies,
parents, successors and assigns, officers, or directors will accept, recover or receive any monetary damages or any other form of relief which may arise out of or in connection with any administrative remedies, which may be filed with or pursued
independently by any governmental agency or agencies, whether federal, state or local. 

  

	 	c.	Thus, for the purpose of implementing a full and complete release and discharge of you (and your heirs, executors, administrators, successors or assigns), the Company
expressly acknowledges that this Agreement is intended to include in its effect, without limitation, claims and causes of action which the Company (including its subsidiaries, related companies, parents, successors and assigns, officers, or
directors) do not know of, or do not suspect to exist, in the Company’s favor (or in the favor of its subsidiaries, related companies, parents, successors and assigns, officers, or directors) at the time of execution hereof, and that this
Agreement contemplates extinguishment of all such claims and causes of action. 

  

	 	12.	Nothing contained herein shall constitute or be construed as a release of your rights to any vested amounts you may have in the Company’s retirement plan.

  

	 	13.	You acknowledge and hereby agree that except as expressly stated in this Agreement, the Company shall have no obligations to you, financial or otherwise, except that
nothing in this Paragraph shall diminish the Company’s obligations to defend and/or indemnify you as set forth in the Company’s By-Laws, Operating Agreement, Director’s and Officer’s Liability Policies or other insurance
policies, and/or Delaware and/or Georgia statutes, as applicable, in the event you are sued in your capacity as a current or former executive of the Company. You further agree that this Agreement sets forth the full understanding and complete
agreement between you and the Company with regard to these matters and supersedes any and all prior agreements, understandings, and negotiations respecting such matters. The terms hereof shall inure to the benefit of and be binding upon your heirs,
representatives, successors and assigns. If any provision of this Agreement is held by a court or arbitrator to be unlawful or unenforceable, the remaining provisions of this Agreement will remain in full force and effect in order to give effect to
the parties’ intent to the fullest extent possible. Any modification of this Agreement is ineffective unless memorialized in a written document signed by both you and the Company. 

 

	 	14.	 You shall and do hereby acknowledge and understand that this Agreement is intended to be legally binding and enforceable. You are therefore informed of
your right to consult with legal counsel of your choosing and are advised to do so before entering into it. You acknowledge and represent that the Company has not provided any tax advice to you in connection with this Agreement and that you have
been advised by the Company to seek tax advice from your own tax advisors regarding this Agreement and payments that may be made to you pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the
Federal Tax Code to such payments. You acknowledge that you shall be solely responsible for your own attorney’s fees and your own tax advisors’ fees incurred in connection with this Agreement. To the extent the payments under this
Agreement are subject to Section 409A of the Federal Tax Code, the 

  
 7 

	 	
agreement shall be interpreted in a manner that complies with section 409A of the Federal Tax Code and guidance of that section (collectively “Section 409A”). For example, the phrase
“employment will end” and the term “termination” shall be interpreted to mean a separation from service under Section 409A and the six-month delay rule shall apply if applicable with respect to amounts subject to section
409A. 

  

	 	15.	THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS OF THE STATE OF GEORGIA (WITHOUT GIVING EFFECT TO THE CHOICE OF LAW
PRINCIPLES THEREOF) APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. All actions and proceedings arising out of or relating to this Agreement shall be heard and determined in any Georgia state or federal court sitting in
the state of Georgia, and the parties hereto hereby consent to the jurisdiction of such courts in any such action or proceeding. 

  

	 	16.	You understand that neither this Agreement nor anything in it shall be considered as any admission by the Company of any preexisting obligation or improper conduct
whatsoever. You understand that the Company denies any such obligations or improper conduct. 

  

	 	17.	By signing this Agreement, you certify that: 

  

	 	a.	You have carefully read and fully understand the provisions of this Agreement, including the portions relating to the release and waiver of claims, and the covenant not
to sue; 

  

	 	b.	The Company has advised you, via this Agreement, to consult with an attorney before signing this Agreement if you so desire; 

 

	 	c.	This Agreement was delivered to you on Thursday, September 1, 2011, and you were given at least 14 calendar days to consider this Agreement before accepting
its terms and signing it; 

  

	 	d.	You have been reimbursed for all expenses to which you are entitled; 

  

	 	e.	You have reported to the Company all injuries or illnesses, if any, that you incurred at work or because of your work with or for the Company, and with or for any of
the Company’s clients; 

  

	 	f.	You affirm that all of the Company’s decisions regarding your pay and benefits through the last day of employment of employment were not discriminatory based on
age, disability, race, color, sex, sexual orientation, gender identity, pregnancy, marital status, veteran status, religion, national origin or any other classification protected by law; 

 

	 	g.	You have been paid for all salary and wages to which you are entitled (except for the final salary payment referenced in Paragraph 4 and the separation benefits
described in Paragraph 2); 

  
 8 

	 	h.	You have reported to the Company any and all allegations of wrongdoing by Company or its officers of which you have any knowledge, including any allegations of
corporate fraud; 

  

	 	i.	You have not been retaliated against for reporting any allegations of wrongdoing by Company or its officers, including any allegations of corporate fraud;

  

	 	j.	You had or could have the entire Review Period (as defined below) in which to review and consider this Agreement, and that if you execute this Agreement prior to the
expiration of the Review Period, you have voluntarily and knowingly waived the remainder of the Review Period; 

  

	 	k.	If any claim is not subject to release, then to the extent permitted by law, you waive any right or ability to be a class or collective action representative or to
otherwise participate in any putative or certified class, collective, or multi-party action or proceeding based on such a claim in which the Company is a party; and 

 

	 	l.	You affirm that you are in possession of all of your own property that you had on or at the Company’s premises and that the Company is not in possession of any of
your property. 

  
 9 

 I, Laurence Neil Hunn, have reviewed the terms and conditions of this Agreement; I
knowingly and voluntarily accept and agree to all of the terms and conditions set forth in the Agreement, without intimidation, coercion, or pressure. 
  

					
	 /s/ Laurence Neil Hunn
	 		 	September 6, 2011
	Laurence Neil Hunn	 		 	Date
			
	Accepted and Agreed:	 		 	
			
	MedAssets Services, LLC	 		 	
			
	 by: /s/ Jonathan H. Glenn
	 		 	September 6, 2011
	Jonathan H. Glenn	 		 	Date
	Executive Vice President and Chief Legal Officer	 		 	

  
 10 

 EXHIBIT A 

General Release 
 In
consideration of the payments provided to me in connection with the termination of my employment with MedAssets, Inc. and MedAssets Services, LLC (collectively, the “Company”) pursuant to that certain Separation and Release Agreement dated
as of September     , 2011 (the “Separation Agreement”), I agree to release any and all claims arising out of my employment and termination of employment, in accordance with the following provisions: 

 

	 	1.	Except for the Company’s obligation under the Separation Agreement, I AGREE FOR MYSELF
AND MY HEIRS, EXECUTORS, ADMINISTRATORS, SUCCESSORS, AND ASSIGNS TO FOREVER RELEASE
AND DISCHARGE THE COMPANY AND ITS SUBSIDIARIES, RELATED COMPANIES, PARENTS,
SUCCESSORS AND ASSIGNS, OFFICERS, DIRECTORS, AGENTS, EMPLOYEES AND FORMER EMPLOYEES
FROM ANY AND ALL CLAIMS, DEBTS, PROMISES, AGREEMENTS, DEMANDS, CAUSES OF
ACTION, ATTORNEYS’ FEES, LOSSES AND EXPENSES OF EVERY NATURE WHATSOEVER, KNOWN
OR UNKNOWN, SUSPECTED OR UNSUSPECTED, FILED OR UNFILLED, ARISING PRIOR TO
THE EFFECTIVE DATE OF THIS AGREEMENT, OR RISING OUT OF OR IN
CONNECTION WITH MY EMPLOYMENT BY AND TERMINATION FROM THE COMPANY OR
ANY AFFILIATE OF THE COMPANY (THE “RELEASE”). This Release includes, but is not limited to, all claims arising directly or
indirectly from my employment with the Company and the termination of that employment; claims or demands related to salary, bonuses, commissions, stock, stock options, vacation pay, fringe benefits, and expense reimbursements pursuant to any
federal, state, or local law or cause of action, including, but not limited to, breach of contract, breach of the implied covenant of good faith and fair dealing, infliction of emotional harm, wrongful discharge, violation of public policy,
defamation and impairment of economic opportunity; and any claims for violation of the Age Discrimination in Employment Act of 1967 (“ADEA”), Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1991, the
Civil Rights Act of 1866, 42 U.S.C. § 1981, the Americans with Disabilities Act of 1990, the Rehabilitation Act, the Family and Medical Leave Act of 1993, the Equal Pay Act, Executive Order 11246, the Fair Labor Standards Act, the Genetic
Information Non-Disclosure Act, USERRA, WARN Act, and any and all claims arising under Georgia law dealing with employment or contract law (including claims for or regarding wages, hours, discrimination, civil rights, torts— such as, but not
limited to, negligence— and any other federal, state, or local employment or anti-discrimination laws). 

  

	 	2.	I further agree that I will not file suit against any of the aforementioned parties or individuals with regard to any claims or liabilities released herein. I further
agree not to accept, recover, or receive any monetary damages or any other form of relief which may arise out of or in connection with any administrative remedies, which may be filed with or pursued independently by any governmental agency or
agencies, whether federal, state, or local. 

  

	 	3.	 Thus, for the purpose of implementing a full and complete release and discharge of the Company (and others released in this Release), I expressly
acknowledge that this Release is intended to include in its effect, without limitation, claims and causes of action which I 

  
 11 

	 	
do not know of, or do not suspect to exist, in my favor at the time of execution hereof, and that this Release contemplates extinguishment of all such claims and causes of action. By executing
this Release, I specifically release all claims relating to my employment and its termination under ADEA, a United States federal statute that, among other things, prohibits discrimination on the basis of age in employment and employee benefit
plans. 

  

	 	4.	As a narrow and limited exception to the waiver and release in this Release, I retain all rights to receive indemnification from the Company for third-party claims,
including any applicable insurance policies such as the Company’s Directors & Officers insurance policies and/or any general corporate indemnification obligations set forth in Georgia statutes. Additionally, nothing herein shall be
construed as a waiver of any claims that cannot be waived by law including, without limitation any claims filed with the Equal Employment Opportunity Commission, the U.S. Department of Labor, or claims under the ADEA that arise after the date of
this Agreement. 

  

	 	5.	By signing this Release, I certify that: 

  

	 	a.	I have carefully read and fully understand the provisions of this Agreement, including the portions relating to the release and waiver of claims, and the covenant not
to sue; 

  

	 	b.	The Company has advised me, via this Release, to consult with an attorney before signing this Release if I so desire; 

 

	 	c.	This Release was delivered to me on Thursday, September 1, 2011, and I was given at least 14 calendar days to consider this Release before accepting its
terms and signing it; 

  

	 	d.	I have been reimbursed for all expenses to which I am entitled; 

  

	 	e.	I have reported to the Company all injuries or illnesses, if any, that I incurred at work or because of my work with or for the Company, and with or for any of the
Company’s clients; 

  

	 	f.	I affirm that all of the Company’s decisions regarding my pay and benefits through the last day of employment of employment were not discriminatory based on age,
disability, race, color, sex, sexual orientation, gender identity, pregnancy, marital status, veteran status, religion, national origin or any other classification protected by law; 

 

	 	g.	I have been paid for all salary and wages to which I am entitled; 

  

	 	h.	I have reported to the Company any and all allegations of wrongdoing by Company or its officers of which I have any knowledge, including any allegations of corporate
fraud; 

  

	 	i.	I have not been retaliated against for reporting any allegations of wrongdoing by Company or its officers, including any allegations of corporate fraud;

  

	 	j.	 I had or could have the entire Review Period (as defined below) in which to review and consider this Release, and that if I execute this Release prior
to the expiration of 

  
 12 

	 	
the Review Period, I have voluntarily and knowingly waived the remainder of the Review Period; 

  

	 	k.	If any claim is not subject to release, then to the extent permitted by law, I waive any right or ability to be a class or collective action representative or to
otherwise participate in any putative or certified class, collective, or multi-party action or proceeding based on such a claim in which the Company is a party; and 

 

	 	l.	I affirm that I am in possession of all of my own property that I had on or at the Company’s premises and that the Company is not in possession of any of my
property. 

 I, Laurence Neil Hunn, have reviewed the terms and conditions of this Release; I knowingly and voluntarily accept
and agree to all of the terms and conditions set forth in the Release, without intimidation, coercion, or pressure. 
  

					
	  
	  		  	  

	Laurence Neil Hunn	  		  	Date

  
 13Form of Subscription Agreement

 Exhibit 10.1 
 SUBSCRIPTION AGREEMENT 
 BofI Holding, Inc. 

12777 High Bluff Drive 
 Suite 100 

San Diego, CA 92130 
 Gentlemen: 

The undersigned (the “Investor”) hereby confirms its agreement with you as follows: 

1. This Subscription Agreement (this “Agreement”) is made as of the date set forth below between BofI Holding, Inc., a Delaware
corporation (the “Company”), and the Investor. 
 2. The Company has authorized the sale and issuance to
certain investors of up to 18,000 shares (the “Shares”) of its 6.0% Series B Non-Cumulative Perpetual Convertible Preferred Stock, par value $0.01 per share (the “Preferred Stock”), for a purchase price of $1,000
per share (the “Purchase Price”). The Preferred Stock shall have the rights, preferences, privileges and restrictions set forth in the Certificate of Designations in the form attached hereto as Exhibit A. 

3. The offering and sale of the Shares (the “Offering”) are being made pursuant to (a) an effective Registration
Statement on Form S-3, Registration No. 333-163339 (including the Prospectus contained therein (the “Base Prospectus”), the “Registration Statement”) filed by the Company with the Securities and Exchange
Commission (the “Commission”), (b) if applicable, certain “free writing prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended), that have or will be filed with the Commission and
delivered to the Investor on or prior to the date hereof (c) if applicable, a preliminary prospectus related to the Offering (together with the Base Prospectus, the “Statutory Prospectus”), and (d) a Prospectus Supplement
(the “Prospectus Supplement” and together with the Statutory Prospectus, the “Prospectus”) containing certain supplemental information regarding the Shares and terms of the Offering that will be filed with the Commission
and delivered to the Investor (or made available to the Investor by the filing by the Company of an electronic version thereof with the Commission) along with the Company’s counterpart to this Agreement. The Prospectus shall not contain any
material non-public information other than as it relates to the Offering. Except with respect to the material terms and conditions of the Offering, the Company confirms that neither it nor any other person acting on its behalf has provided the
Investor or its agents or counsel with any information that the Company believes constitutes or might constitute material, non-public information. 
 4. The Company and the Investor agree that the Investor will purchase from the Company and the Company will issue and sell to the Investor the Shares of Preferred Stock set forth on the signature page
below, for the aggregate purchase price set forth on the signature page. The Shares shall be purchased pursuant to the “Terms and Conditions for Purchase of Shares” attached hereto as Annex I and incorporated herein by this reference as if
fully set forth herein. The Investor acknowledges that the Offering is not being underwritten by the placement agent (the “Placement Agent”) named in the Prospectus Supplement. A minimum of 5,000 Shares (the “Minimum
Shares”) shall be issued and sold in the Offering at the Closing. 

  
 1 

 5. The manner of settlement of the Shares purchased by the Investor will be delivery by
electronic book-entry at The Depository Trust Company (“DTC”) (or physical stock certificates if the Preferred Stock is not a DTC FAST-eligible issue at Closing), registered in the Investor’s name and address as set forth below, and
released by Computershare Trust Company, N.A., the Company’s transfer agent (the “Transfer Agent”), to the Investor at the Closing. ON OR BEFORE THE CLOSING, THE INVESTOR SHALL: 

(I) DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED WITH THE SHARES ARE MAINTAINED TO SET UP A DEPOSIT/WITHDRAWAL
AT CUSTODIAN (“DWAC”) INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE SHARES, AND 
 (II)
REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE SHARES BEING PURCHASED BY THE INVESTOR TO THE FOLLOWING ACCOUNT: 
  

					
	 Bank of America
 100 West 33RD
St.
 New York, NY

	ABA #: 026 009 593             Swift Code: BOFAUS3N
	For further credit to account number:             4426874722	  	
	Name on Account:             Computershare Trust Company, NA
	                           
                  As Escrow Agent for Clients
	Ref: BofI Holdings Escrow

 6. The Investor represents that, except as set forth below, (a) it has had no position, office or
other material relationship within the past three years with the Company or persons known to it to be affiliates of the Company, (b) it is not a FINRA member or an Associated Person (as such term is defined under the FINRA Membership and
Registration Rules Section 1011) as of the Closing, and (c) assuming the accuracy of the representations and warranties of the Company contained herein and in the Placement Agreement (as defined in Section 2.4 of Annex I), neither the
Investor nor any group of Investors (as identified in a public filing made with the Commission) of which the Investor is a part in connection with the Offering of the Shares, acquired, or obtained the right to acquire, or shall own or control
following consummation of the transactions contemplated hereby, 9.9% or more of the Common Stock (or securities convertible into or exercisable for Common Stock) or the voting power of the Company on a post-transaction basis. List any exceptions in
the line below: 

                         
                                         
                                         
                                         
                                         
                       . 

(If no exceptions, write “none.” If left blank, response will be deemed to be “none”.) 

7. The Investor represents that it has received (or otherwise had made available to it by the filing by the Company of an electronic
version thereof with the Commission) the Statutory Prospectus, which includes the final Base Prospectus, dated January 6, 2010, which is a 

  
 2 

 
part of the Company’s Registration Statement, the documents incorporated by reference therein, and any free writing prospectus (collectively, the “Disclosure Package”),
prior to or in connection with the receipt of this Agreement and the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission) along with the Company’s counterpart to this Agreement. 

8. No offer by the Investor to buy Shares will be accepted and no part of the Purchase Price will be delivered to the Company until the
Company has accepted such offer by countersigning a copy of this Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to the Company (or the Placement Agent on behalf of the
Company) sending (orally, in writing, or by electronic mail) notice of its acceptance of such offer. An indication of interest will involve no obligation or commitment of any kind until this Agreement is accepted and countersigned by or on behalf of
the Company and the Investor has been delivered the Prospectus Supplement. 
 [Signature page follows] 

  
 3 

 Please confirm that the foregoing correctly sets forth the agreement between us by signing
in the space provided below for that purpose. 
 Dated as of:             , 2011

  

	
	INVESTOR
	
	Print
Name:                                        
                                       

	
	Signature:                            
                                         
              
	
	 If Investor is an entity:

	
	 Name of
signatory:                                       
                 

	
	 Title of
signatory:                                       
                    

	
	Address:                            
                                         
                 
	
	                             
                                         
                                 
	
	Shares of Preferred Stock
Purchased:                                
	
	Purchase Price Per Share: $1,000
	
	Aggregate Purchase Price: $              

  

	
	AGREED AND ACCEPTED THIS      DAY OF             , 2011:
	
	BOFI HOLDING, INC.
	
	By:                             
                                         
                    
	
	Print
Name:                                        
                                  
	
	Title:                            
                                         
                  

  
 4 

 ANNEX I 

TERMS AND CONDITIONS FOR PURCHASE OF SHARES 
 1. Authorization and Sale of the Shares. Subject to the terms and conditions of this Agreement, the Company has authorized the sale of the Shares. 

2. Agreement to Sell and Purchase the Shares; Placement Agent. 

2.1 At the Closing (as defined in Section 3.1), the Company will sell to the Investor, and the Investor will purchase from the
Company, upon the terms and conditions set forth herein, the number of Shares set forth on the last page of the Agreement to which these “Terms and Conditions for Purchase of Shares” are attached as Annex I (the “Signature
Page”) for the aggregate purchase price therefor set forth on the Signature Page. 
 2.2 The Company proposes to enter
into substantially this same form of Subscription Agreement with certain other investors (the “Other Investors”) and expects to complete sales of Shares to them. The Investor and the Other Investors are hereinafter sometimes
collectively referred to as the “Investors”, and this Agreement and the Subscription Agreements executed by the Other Investors are hereinafter sometimes collectively referred to as the “Agreements”. 

2.3 Investor acknowledges that the Company intends to pay the Placement Agent a fee (the “Placement Fee”) in respect of
the sale of Shares to the Investor. 
 2.4 The Company has entered into a Placement Agent Agreement, dated
            , 2011 (the “Placement Agreement”), with the Placement Agent that contains certain representations, warranties, covenants, and agreements of the Company that
may be relied upon by the Investor, which shall be a third party beneficiary thereof. A copy of the Placement Agreement is available upon request. 
 3. Closings and Delivery of the Shares and Funds. 
 3.1 Closing. The
completion of the purchase and sale of the Shares (the “Closing”) is subject to the satisfaction of certain closing conditions set forth in the Placement Agreement, and the Closing shall occur at a place and time (the
“Closing Date”) to be specified by the Company and the Placement Agent, and of which the Investors will be notified in advance by the Placement Agent, in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of
1934, as amended (the “Exchange Act”). At the Closing, (a) the Company shall cause the Transfer Agent to deliver to the Investor the number of Shares set forth on the Signature Page registered in the name of the Investor or, if
so indicated on the Investor Questionnaire attached hereto as Exhibit A, in the name of a nominee designated by the Investor and (b) the aggregate purchase price for the Shares being purchased by the Investor will be delivered by or on behalf
of the Investor to the Company. 
 3.2 Conditions to the Company’s Obligations. The Company’s obligation to
issue and sell the Shares to the Investor shall be subject to: (a) the receipt by the Company of the purchase price for the Shares being purchased hereunder as set forth on the Signature Page and

  
 A-1

 
(b) the accuracy of the representations and warranties made by the Investor in this Agreement and the fulfillment of those undertakings of the Investor in this Agreement to be fulfilled prior to
the Closing Date. 
 3.3 Conditions to the Investor’s Obligations. The Investor’s obligation to purchase the
Shares will be subject to (i) the accuracy of the representations and warranties made by the Company and the fulfillment of those undertakings of the Company to be fulfilled prior to the Closing Date, including without limitation, those
contained in the Placement Agreement, (ii) the sale by the Company of at least the Minimum Shares at the same price per share at Closing, and (iii) the condition that the Placement Agent shall not have: (a) terminated the Placement
Agreement pursuant to the terms thereof or (b) determined that the conditions to the closing in the Placement Agreement have not been satisfied. The Investor’s obligations are expressly not conditioned on the purchase by any or all of the
Other Investors of the Shares that they have agreed to purchase from the Company. 
 3.4 Delivery of Funds. On or before
Closing, the Investor shall remit by wire transfer the amount of funds equal to the aggregate purchase price for the Shares being purchased by the Investor to the following account designated by the Company and the Placement Agent pursuant to the
terms of that certain Escrow Agreement (the “Escrow Agreement”) dated as of             , 2011, by and among the Company, the Placement Agent and the Transfer Agent (the
“Escrow Agent”): 
  

					
	 Bank of America
 100
West 33RD St.

New York, NY
	  		  	
	ABA #: 026 009 593             Swift Code: BOFAUS3N	  	
	For further credit to account number:             4426874722
	Name on Account:             Computershare Trust Company, NA	  	
	                           
                  As Escrow Agent for Clients
	Ref: BofI Holdings Escrow	  		  	

 Such funds shall be held in escrow until the Closing and delivered by the Escrow Agent on behalf of the Investor to the
Company upon the satisfaction, in the sole judgment of the Placement Agent, of the conditions set forth in Section 3.3 hereof. The Placement Agent shall have no rights in or to any of the escrowed funds, unless the Placement Agent and the
Escrow Agent are notified in writing by the Company in connection with the Closing that a portion of the escrowed funds shall be applied to the Placement Fee. The Company agrees to indemnify and hold the Escrow Agent harmless from and against any
and all losses, costs, damages, expenses and claims (including, without limitation, court costs and reasonable attorneys fees) (“Losses”) arising under this Section 3.4 or otherwise with respect to the funds held in escrow
pursuant hereto or arising under the Escrow Agreement, unless it is finally determined that such Losses resulted directly from the willful misconduct or gross negligence of the Escrow Agent. Anything in this Agreement to the contrary
notwithstanding, in no event shall the Escrow Agent be liable for any special, indirect or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Escrow Agent has been advised of the likelihood
of such loss or damage and regardless of the form of action. Investor shall also furnish to the Placement Agent a completed W-9 form (or, in the case of an Investor who is not a United States citizen or resident, a W-8 form). 

  
 A-2

 3.5 Delivery of Shares. No later than one (1) business day after the execution
of this Agreement by the Investor and the Company, the Investor shall direct the broker-dealer at which the account or accounts to be credited with the Shares being purchased by such Investor are maintained, which broker/dealer shall be a DTC
participant, to set up a Deposit/Withdrawal at Custodian (“DWAC”) instructing the Transfer Agent to credit such account or accounts with the Shares by means of an electronic book-entry delivery. Such DWAC shall indicate the
settlement date for the deposit of the Shares, which date shall be provided to the Investor by the Placement Agent. Simultaneously with the delivery to the Company by the Escrow Agent of the funds held in escrow pursuant to Section 3.4 above,
the Company shall direct its transfer agent to credit the Investor’s account or accounts with the Shares pursuant to the information contained in the DWAC. 
 4. Representations, Warranties and Covenants of the Investor. 
 4.1 The
Investor represents and warrants to, and covenants with, the Company that (a) the Investor is knowledgeable, sophisticated and experienced in making, and is qualified to make decisions with respect to, investments in shares presenting an
investment decision like that involved in the purchase of the Shares, including investments in securities issued by the Company and investments in comparable companies, and has requested, received, reviewed and considered all information it deemed
relevant in making an informed decision to purchase the Shares, (b) the Investor has answered all questions on the Signature Page and the Investor Questionnaire and the answers thereto are true and correct as of the date hereof and will be true
and correct as of the Closing Date and (c) the Investor, in connection with its decision to purchase the number of Shares set forth on the Signature Page, is relying only upon the Disclosure Package, the documents incorporated by reference
therein and the representations and warranties of the Company contained herein and in the Placement Agreement in making a decision to purchase the Shares. 
 4.2 The Investor acknowledges, represents and agrees that no action has been or will be taken in any jurisdiction outside the United States by the Company or any Placement Agent that would permit an
offering of the Shares, or possession or distribution of offering materials in connection with the issue of the Shares in any jurisdiction outside the United States where action for that purpose is required. If the Investor is outside the United
States, it will comply with all applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Shares or has in its possession or distributes any offering material, in all cases at its own expense. The
Placement Agent is not authorized to make and have not made any representation or use of any information in connection with the issue, placement, purchase and sale of the Shares, except as set forth or incorporated by reference in the Base
Prospectus or the Prospectus Supplement. 
 4.3 The Investor further represents and warrants to, and covenants with, the Company
that (a) the Investor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of
this Agreement, and (b) this 

  
 A-3

 
Agreement constitutes a valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law). 
 4.4 The Investor understands that nothing in this
Agreement, the Prospectus or any other materials presented to the Investor in connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and investment advisors as it,
in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Shares. 
 4.5 The Investor
represents, warrants and agrees that, since the date on which the Placement Agent or the Company first contacted such Investor about the Offering, it has not engaged in any transactions in the securities of the Company (including, without
limitation, any Short Sales involving the Company’s securities). The Investor covenants that it will not engage in any transactions in the securities of the Company (including Short Sales) prior to the time that the transactions contemplated by
this Agreement are publicly disclosed. The Investor agrees that it will not use any of the Shares acquired pursuant to this Agreement to cover any short position in the Common Stock if doing so would be in violation of applicable securities laws.
For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and
indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and
sales and other transactions through non-US broker dealers or foreign regulated brokers. 
 5. Survival of Representations,
Warranties and Agreements. Notwithstanding any investigation made by any party to this Agreement or by the Placement Agent, all covenants, agreements, representations and warranties made by the Company and the Investor herein will survive the
execution of this Agreement, the delivery to the Investor of the Shares being purchased and the payment therefor. 
 6.
Notices. All notices, requests, consents and other communications hereunder will be in writing, will be mailed (a) if within the domestic United States by first-class registered or certified airmail, or nationally recognized overnight
express courier, postage prepaid, or by facsimile or (b) if delivered from outside the United States, by International Federal Express or facsimile, and will be deemed given (i) if delivered by first-class registered or certified mail
domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and
(iv) if delivered by facsimile, upon electronic confirmation of receipt and will be delivered and addressed as follows: 
  

	 	(a)	if to the Company, to: 

 BofI
Holding, Inc. 
 12777 High Bluff Drive, Suite 100 
 San Diego, CA 92130 
 Attention: Andrew J. Micheletti 

Facsimile: (858) 350-0443 

  
 A-4

 with copies to: 
 Reed Smith LLP 
 355 South Grand Ave., Suite 2900 

Los Angeles, CA 90071 
 Attention: Allen Z. Sussman, Esq. 
 Facsimile: (213) 457-8030

 (b) if to the Investor, at its address on the Signature Page hereto, or at such other address or addresses as may have been
furnished to the Company in writing. 
 7. Changes. This Agreement may not be modified or amended except pursuant to an
instrument in writing signed by the Company and the Investor. 
 8. Headings. The headings of the various sections of
this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement. 
 9.
Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein will not in any way be affected
or impaired thereby. 
 10. Governing Law. This Agreement will be governed by, and construed in accordance with, the
internal laws of the State of New York, without giving effect to the principles of conflicts of law that would require the application of the laws of any other jurisdiction. 
 11. Counterparts. This Agreement may be executed in two or more counterparts, each of which will constitute an original, but all of which, when taken together, will constitute but one instrument,
and will become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties by facsimile or by e-mail delivery of a “.pdf” format data file. The Company and the Investor acknowledge and
agree that the Company shall deliver its counterpart to the Investor along with the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission). 

12. Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt of the Company’s counterpart
to this Agreement, together with the Prospectus Supplement (or the filing by the Company of an electronic version thereof with the Commission), shall constitute written confirmation of the Company’s sale of Shares to such Investor. 

  
 A-5

 13. Press Release. The Company agrees to issue a press release announcing the
Offering and disclosing all material information regarding the Offering prior to the opening of the financial markets in New York City on the business day immediately after the date hereof. The Company shall file a Current Report on Form 8-K with
the Securities and Exchange Commission (the “SEC”) disclosing the material terms of the Offering and including a form of this Agreement, the Placement Agreement and the Certificate of Designations for the Preferred Stock prior to the
opening of the financial markets in New York City on the second business day immediately after the date hereof. The Company shall not disclose the name of the Investor or its investment adviser in any press release or other public statement about
the Offering, except if such disclosure is required by law, in which case the Company shall promptly provide the other party with prior notice of such public statement or communication. 

14. Termination. In the event that the Placement Agreement is terminated by the Placement Agent pursuant to the terms thereof,
this Agreement shall terminate without any further action on the part of the parties hereto. 

  
 A-6

 EXHIBIT A 

BOFI HOLDING, INC. 
 INVESTOR QUESTIONNAIRE 
 Pursuant to Section 3 of Annex I to the Agreement, please
provide us with the following information: 
  

	 	1.	The exact name that your Shares are to be registered in. You may use a nominee name if appropriate:
                     

  

	 	2.	The relationship between the Investor and the registered holder listed in response to item 1 above (if not the same):
                     

  

	 	3.	The mailing address of the registered holder listed in response to item 1 above: 

 

	 	 	                           
                                         
                                         
            

  

	 	 	                           
                                         
                                         
            

  

	 	 	                           
                                         
                                         
            

  

	 	4.	The Social Security Number or Tax Identification Number of the registered holder listed in the response to item 1 above:
                     

  

	 	5.	Name of DTC Participant (broker-dealer at which the account or accounts to be credited with the Shares are maintained):
                     

  

	 	6.	DTC Participant Number:                     

  

	 	7.	Name of Account at DTC Participant being credited with the Shares:
                     

  

	 	8.	Account Number at DTC Participant being credited with the Shares:
                     

  

	 	9.	Person to contact to initiate DWAC at closing: 

 Name:                               

Telephone:
                     

Email:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]